Tom Barber is the Chief Scientific Officer at Congenica. He previously served as the Chief Scientific Officer at LifeOmic. Tom has over 25 years of experience studying genetic causes of human diseases such as cancer, deafness, myotonic dystrophy, and other inherited diseases. During his postdoctoral fellowship at Johns Hopkins Medical Institute, Tom’s discoveries contributed to the first exome studies of cancer. He began his industry career at Eli Lilly in 2006 as an oncology drug hunter and biomarker developer.
In 2010, Tom created and led the Next Generation Sequencing platform at Eli Lilly which identified preclinical and clinical models for personalized medicine in oncology, diabetes, neuroscience, and cardiovascular disease. In 2014, Tom became the genomics leader at Beckman Coulter developing solutions for NGS sample preparation. Tom has studied human molecular genetics throughout his career, earning a BS in Zoology-Genetics from Michigan State University in 1993, a MS in Human and Molecular Genetics from Baylor College of Medicine in 1995, and a PhD in Genetics from Michigan State University in 2000.
Ed Simcox is the Vice President of Solutions for the Mayo Clinic Platform and currently serves as an Advisor. Previously, Ed served as Chief Strategy Officer (CSO) at LifeOmic and, before that, the Chief Technology Officer (CTO) at the U.S. Department of Health and Human Services (HHS), the largest civilian government agency in the world. He led efforts at HHS to effectively leverage data, technology and innovation to improve the lives of the American people and the performance of the Department’s 29 agencies and offices. While CTO, he also served as Acting Chief Information Officer at HHS, where he oversaw the Department’s IT modernization efforts, IT operations and cybersecurity.
Prior to HHS, Ed was served in roles as Healthcare Practice Leader at Logicalis, Director of US Healthcare Strategy and Offer Development at AT&T and Chief Technology Officer at Indiana University Health.
Ed was recently awarded The Best Boss in Federal IT, The Fed 50 and the American society of Nephrology’s President’s Medal for his work to improve kidney care in the United States.
Prior to entering healthcare, Ed was a professional drummer, having toured and played numerous studio sessions. He is an avid sports and entertainment photographer, and his photos have been syndicated and featured in magazines and industry websites. Ed, his wife and his three daughters live in Indianapolis.
Paul is a seasoned strategic advisor with 25 plus years of experience in the enterprise software (SaaS) industry focused on Go To Market Strategies.
Paul’s most recent experience was as Chief Business Officer and SVP of Sales, at Interactive Intelligence, Inc. that went public in 1999 and was recently acquired by Genesys for $1.4B. Interactive was a global provider of business communications software in the Unified Communications/Contact Center space. Joining Interactive in 1997, Paul was part of the original team that set the go-to-market strategy while scaling the direct and channel salesforce to $400m in revenue and over 2,000 employees.
Prior to joining Interactive, Paul spent five years with Software Artistry Inc. selling within the early-stage HelpDesk (CRM) industry. He worked from the startup phase of the business through the IPO, leaving just prior to the time the company was sold to IBM.
Milad Alucozai invests in early-stage bio, healthcare, and deep technology companies. He is a Venture Partner at Entrepreneur First, a global fund with a portfolio value of over $5 billion. In 2020, he was appointed as an External Advisor to AstraZeneca, working on initiatives to partner more closely with startups. He proudly serves as a Mentor for groups like the Creative Destruction Lab and Harvard University iLabs.
Milad’s career began as a bench scientist working in translational neuroscience and multiphysics labs. He transitioned into becoming a founder and part of the founding team of multiple healthcare and bio startups. He is part of the founding team at Mekonos, a San Francisco-based company building a platform for cell delivery supporting the future of cell and gene therapies. Prior to this, he served as CBO at Corstem, a company specializing in machine learning and artificial intelligence software (acquired by Circle Cardiovascular, a platform used in over 1000 hospitals and in more than 40 countries). He was also part of Numerate, a San Francisco-based drug discovery company (acquired by Valo Health). During his time at Accenture, Milad led data science and engineering teams focused on AI products for global pharmaceutical companies and hospital networks.
He is a former Visiting Scholar in Healthcare Engineering at the Regenstrief Center. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine and graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed graduate school in Immunology & Public Health.
Emma Bowman is a licensed psychotherapist who has spent her career working with young adults, adolescents and children in community mental health and school-based settings. She currently owns and offers therapy services at Tulip Tree Therapy, LLC in Indianapolis. Emma has a passion for helping students manage mental health challenges and hopes to make a bigger impact through her work with LifeOmic.
Emma earned a Bachelor of Arts degree at IUPUI and a master’s degree from the IU School of Social Work. She spent the first years of her career supporting students in Wayne Township Public Schools as a school therapist before deciding to start a private practice. She is also a graduate of the Gestalt Institute of Indianapolis and the Gestalt Associates Training of Los Angeles (GATLA).
Emma currently lives in Broadripple, Indiana with her husband, two daughters, two dogs, two cats and a hermit crab named Mr. Kitty.